Bausch Health Companies (TSE:BHC) Stock Price Down 1.9% – Should You Sell?

Bausch Health Companies Inc. (TSE:BHC – Get Free Report)’s share price fell 1.9% during trading on Tuesday . The company traded as low as C$7.30 and last traded at C$7.33. 346,542 shares changed hands during trading, a decline of 25% from the average session volume of 462,667 shares. The stock had previously closed at C$7.47.

Trending Headlines about Bausch Health Companies

Here are the key news stories impacting Bausch Health Companies this week:

Get Bausch Health Companies alerts:

• Positive Sentiment: Zacks Research raised its FY2026 EPS estimate to $5.38 from $5.32 and nudged Q2 2026, Q4 2026, and Q1 2027 estimates higher, suggesting some near-term earnings resilience.
• Neutral Sentiment: Bausch Health also reported results from its 2026 Annual Meeting of Shareholder, but the filing provided no obvious operational surprise in the information provided. Article Title
• Negative Sentiment: Zacks Research cut estimates for Q3 2026, Q2 2027, Q3 2027, Q4 2027, FY2027, FY2028, and Q1 2028, signaling softer expectations for Bausch Health’s earnings trajectory over the next several years.

Bausch Health Companies Stock Performance

The company has a market cap of C$2.81 billion, a PE ratio of -2.32, a PEG ratio of 0.21 and a beta of 0.63. The company has a debt-to-equity ratio of -1,009.96, a current ratio of 1.32 and a quick ratio of 0.58. The business has a 50-day moving average of C$7.46 and a 200 day moving average of C$8.45.

Bausch Health Companies (TSE:BHC – Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The company reported C$1.08 EPS for the quarter. The business had revenue of C$3.51 billion during the quarter. Bausch Health Companies had a positive return on equity of 120.43% and a negative net margin of 13.54%. Equities research analysts anticipate that Bausch Health Companies Inc. will post 5.5472637 EPS for the current fiscal year.

About Bausch Health Companies

(Get Free Report)

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.

See Also

• Five stocks we like better than Bausch Health Companies
• Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
• As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
• Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
• The Silver Lining of Last Week’s Hims & Hers Earnings Miss

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.